Table 1: Summary of clinical characteristics between patients with ALS and normal controls in whole group analysis.

NC ( )ALS ( )

Age 0.389
Male, 26261
MMSE 0.054
ALSFRSn/a
Disease duration (months)n/a
Disease progression raten/a

NC: normal controls; MMSE: Mini-Mental Status Evaluation; disease progression rate = (40-ALSFRS)/disease duration. n/a: not applicable.